Product References — Bio Fluids

Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity

Posted by Adam Awdish on

Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity

Human Factor II (Prothrombin) Purified, Human Fibrinogen Purified, and Rabbit Anti Mouse/Rat Fibrinogen Polyclonal Affinity Purified from Innovative Research were used in the following study:   Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity Alice G. Cheng, Molly McAdow, Hwan K. Kim, Taeok Bae, Dominique M. Missiakas, Olaf Schneewind PLOS Pathogens August 5, 2010 Staphylococcus aureus is a bacterium responsible for many common infections, including bacteremia, pneumonia, soft tissue infections, and septic arthritis among others. There remains no known way to gain protective immunity against S. aureus diseases, and researchers continue to investigate options for an effective vaccine....

Read more →

Development of a Paper-Immobilized Yeast Biosensor for the Detection of Physiological Concentrations of Doxycycline in Technology-Limited Settings

Posted by Adam Awdish on

Development of a Paper-Immobilized Yeast Biosensor for the Detection of Physiological Concentrations of Doxycycline in Technology-Limited Settings

Pooled Human Urine from Innovative Research was used in the following study:   Development of a Paper-Immobilized Yeast Biosensor for the Detection of Physiological Concentrations of Doxycycline in Technology-Limited Settings Rachel A. Miller, Galen Brown, Elsa Barron, Jamie L. Luther, Marya Lieberman, and Holly V. Goodson Analytical Methods April 7, 2020 Estimates suggest that at least 10% of all medical products sold in low- and middle-income countries (LMICs) are substandard and/or falsified. Because of this, there is a need for better analytical tools for detecting pharmaceuticals in settings with limited access to medical technology. The main need for such tools...

Read more →

Biomarkers in Cancer Patients at Risk for Venous Thromboembolism: Data from the AVERT Study

Posted by Adam Awdish on

Biomarkers in Cancer Patients at Risk for Venous Thromboembolism: Data from the AVERT Study

Human tPA 85% Single Chain Purified from Innovative Research was used in the following study:   Biomarkers in Cancer Patients at Risk for Venous Thromboembolism: Data from the AVERT Study Anton Ilich, Vaibhav Kumara, Michael Henderson, Ranjeeta Mallick, Philip Wells, Marc Carrier, Nigel S. Key Elsevier Ltd. July 28, 2020 Currently, cancer-associated venous thromboembolism (VTE) and the ways it can develop are not well characterized. Scientists know that the risk of VTE varies depending on the type of cancer, however, the various mechanisms surrounding VTE are not thoroughly understood. In a study published this Summer, researchers selected several biomarkers that...

Read more →

Platelet-Primed Interactions of Coagulation and Anticoagulation Pathways in Flow-Dependent Thrombus Formation

Posted by Adam Awdish on

Platelet-Primed Interactions of Coagulation and Anticoagulation Pathways in Flow-Dependent Thrombus Formation

Human Protein C Activated Purified GLA Domainless from Innovative Research was used in the following study:   Platelet-Primed Interactions of Coagulation and Anticoagulation Pathways in Flow-Dependent Thrombus Formation Sanne L. N. Brouns, Johanna P. van Gefen, Elena Campello, Frauke Swieringa, Luca Spiezia, René van Oerle, Isabella Provenzale, Remco Verdoold, Richard W. Farndale, Kenneth J. Clemetson, Henri M. H. Spronk, Paola E. J. van der Meijden, Rachel Cavill, Marijke J. E. Kuijpers, Elisabetta Castoldi, Paolo Simioni & Johan W. M. Heemskerk Scientific Reports (Nature Publisher Group) 2020 During the processes of haemostasis and thrombosis, platelet and coagulation pathways are tightly linked,...

Read more →

Rapid liquid chromatography tandem mass spectrometry method for targeted quantitation of human performance metabolites in saliva

Posted by Corey Marcath on

Rapid liquid chromatography tandem mass spectrometry method for targeted quantitation of human performance metabolites in saliva

Pooled Human Saliva from Innovative Research was used in the following study:   Rapid liquid chromatography tandem mass spectrometry method for targeted quantitation of human performance metabolites in saliva Ethan M.McBridea,Richard J.Lawrencea, Kirstin McGeea, Phillip M.Macha, Paul S.Demond, Michael W.Busch, John W.Ramsay, Erika K.Hussey, Trevor Glarosa, Elizabeth S.Dhummakupt Journal of Chromatography A 13 September 2019 ”…Saliva is increasingly being targeted for metabolic studies due to its non-invasive collection methods. Tracing levels of certain metabolites within biofluids can provide indications for a myriad of physiological conditions. This study was performed on a panel of eight analytes found in saliva that have...

Read more →


×